Zhengye Biotechnology Holding LtdZYBT
Price$1.20

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $16.6M-34.8% YoYTTM through 31 Dec 2025
Net Income -$10M-744.0% YoYTTM through 31 Dec 2025
Free Cash Flow $11.8MTTM through 31 Dec 2025

Margins

Current
Gross Margin20.5%
Operating Margin-60.6%
Net Margin-60.0%

Returns

-27.1%ROE
-19.0%ROA

Balance Sheet Health

Debt / Equity0.24x
Net Debt$24.4M
Cash & Equivalents$50.3M

Quality Metrics

FCF Margin70.9%

Dividend

No dividend
Financials converted at 6.9961.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.